Literature DB >> 3921123

Detection of familial dysalbuminaemic hyperthyroxinaemia.

M S Croxson, B N Palmer, I M Holdaway, P A Frengley, M C Evans.   

Abstract

A simple test of in vitro thyroxine binding to serum proteins was used to screen serum samples from euthyroid patients with unexplained increases in the free thyroxine index. A diagnosis of familial dysalbuminaemic hyperthyroxinaemia was presumed in 14 unrelated subjects and six first degree relatives. Increased binding of thyroxine to thyroxine binding prealbumin was diagnosed in one woman with four unaffected relatives. Seven patients with familial dysalbuminaemic hyperthyroxinaemia had been treated for presumed thyrotoxicosis: two had typical Graves' disease and one subacute thyroiditis. Four other patients had been mistakenly treated with radioactive iodine or antithyroid drugs. In previously treated patients familial dysalbuminaemic hyperthyroxinaemia was suspected from the combination of a high serum thyroid stimulating hormone concentration and a normal but invalid free thyroxine index. Physicians should be cautious in accepting a diagnosis of thyrotoxicosis based mainly on a raised serum thyroxine concentration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921123      PMCID: PMC1418734          DOI: 10.1136/bmj.290.6475.1099

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  9 in total

1.  Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin.

Authors:  J R Stockigt; D J Topliss; J W Barlow; E L White; D M Hurley; P Taft
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

Review 2.  Euthyroid hyperthyroxinemia.

Authors:  G C Borst; C Eil; K D Burman
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

3.  Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine-binding prealbumin.

Authors:  A C Moses; J Lawlor; J Haddow; I M Jackson
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245

4.  Differences between familial hyperthyroxinemic syndromes.

Authors:  J R Stockigt; E L White; J W Barlow
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

5.  Limitations of a new free thyroxine assay (Amerlex free T4).

Authors:  J R Stockigt; M de Garis; J Csicsmann; J W Barlow; E L White; D M Hurley
Journal:  Clin Endocrinol (Oxf)       Date:  1981-09       Impact factor: 3.478

6.  Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis.

Authors:  M Ruiz; R Rajatanavin; R A Young; C Taylor; R Brown; L E Braverman; S H Ingbar
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

7.  Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein.

Authors:  G Hennemann; R Docter; E P Krenning; G Bos; M Otten; T J Visser
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

8.  TRH testing, T4-thyrotoxicosis and the aging thyroid gland.

Authors:  M S Croxson; T M Wilson; G H Ballantyne
Journal:  N Z Med J       Date:  1981-06-24

9.  Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin.

Authors:  J W Barlow; J M Csicsmann; E L White; J W Funder; J R Stockigt
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

  9 in total
  7 in total

1.  A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.

Authors:  P P Yeo; Y Yabu; J R Etzkorn; R Rajatanavin; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

2.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method.

Authors:  M E Veronese; S McLean; R Hendriks
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

3.  Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia.

Authors:  Isabelle Petitpas; Charles E Petersen; Chung-Eun Ha; Ananyo A Bhattacharya; Patricia A Zunszain; Jamie Ghuman; Nadhipuram V Bhagavan; Stephen Curry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

4.  A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.

Authors:  A C Moses; H N Rosen; D E Moller; S Tsuzaki; J E Haddow; J Lawlor; J J Liepnieks; W C Nichols; M D Benson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 5.  Familial dysalbuminaemic hyperthyroxinaemia: a review.

Authors:  I W Jensen; J Faber
Journal:  J R Soc Med       Date:  1988-01       Impact factor: 18.000

6.  Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Man Caused by a Point Albumin Gene Mutation (R218P).

Authors:  Yoshinori Osaki; Yoshitaka Hayashi; Yoshinori Nakagawa; Katsumi Yoshida; Hiroshi Ozaki; Hiroshi Fukazawa
Journal:  Jpn Clin Med       Date:  2016-04-04

7.  Familial dysalbuminaemic hyperthyroxinaemia and other causes of euthyroid hyperthyroxinaemia.

Authors:  C Farror; M L Wellby; C Beng
Journal:  J R Soc Med       Date:  1987-12       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.